{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T13:30:33Z","timestamp":1772803833761,"version":"3.50.1"},"reference-count":136,"publisher":"Informa UK Limited","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1517\/14656566.3.11.1557","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T21:21:06Z","timestamp":1115241666000},"page":"1557-1568","source":"Crossref","is-referenced-by-count":26,"title":["The contentious nature of gestational diabetes: diet, insulin, glyburide and metformin"],"prefix":"10.1517","volume":"3","author":[{"given":"Charles J","family":"Glueck","sequence":"first","affiliation":[{"name":"Cholesterol Center, ABC Building, Jewish Hospital of Cincinnati, 3200 Burnet Avenue, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Goldenberg","sequence":"additional","affiliation":[{"name":"Cholesterol Center, ABC Building, Jewish Hospital of Cincinnati, 3200 Burnet Avenue, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Streicher","sequence":"additional","affiliation":[{"name":"Cholesterol Center, ABC Building, Jewish Hospital of Cincinnati, 3200 Burnet Avenue, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[{"name":"Cholesterol Center, ABC Building, Jewish Hospital of Cincinnati, 3200 Burnet Avenue, Cincinnati, OH 45229, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2005,2,25]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"568","article-title":"Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus","volume":"86","author":"HOMCO C","year":"2001","unstructured":"HOMCO C, SIVAN E, CHEN X, REECE EA, BODEN G: Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrine]. Metab. (2001) 86:568\u2013573.","journal-title":"J. Clin. Endocrine]. Metab."},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03202-2"},{"key":"e_1_2_1_4_1","unstructured":"\u2022\u2022Tenfold reduction in gestational diabeteswith metformin in women with PCOS."},{"key":"e_1_2_1_5_1","doi-asserted-by":"crossref","unstructured":"BUTTE NF: Carbohydrate and lipid metabolism in normal pregnancy: normal compared with gestational diabetes mellitus. Am. J. Clin. Nutr. (2000) 71(Suppl.):1256S\u20131261S.","DOI":"10.1093\/ajcn\/71.5.1256s"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.48.4.848"},{"key":"e_1_2_1_7_1","unstructured":"\u2022\u2022Elegant study of the physiology of risk fortype 2 DM."},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.49.5.782"},{"key":"e_1_2_1_9_1","unstructured":"\u2022\u2022Excellent thorough review."},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","unstructured":"BUCHANAN TA: Pancreatic 13-cell defectsin gestational diabetes: implications for the pathogenesis and prevention of type 2 diabetes.j Clin. Endocrine]. Metab. (2001) 86:989\u2013993.","DOI":"10.1210\/jc.86.3.989"},{"key":"e_1_2_1_11_1","unstructured":"COUSTAN DR: Gestational Diabetes: In: Harris MI Cowie CC Stern MP Boyko EJ Reiber GE Bennett PH (Eds). Diabetes in America. 2nd edn. National Institute of Health Baltimore MD USA (1995):703\u2013717. Publication 95\u20131468."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.7.1029"},{"key":"e_1_2_1_13_1","unstructured":"\u2022\u2022Important epidemiological study ofdiabetes and pregnancy."},{"key":"e_1_2_1_14_1","first-page":"495","article-title":"Gestational diabetes mellitus and subsequent development of overt diabetes mellitus","volume":"45","author":"DAMM P","year":"1998","unstructured":"DAMM P: Gestational diabetes mellitus and subsequent development of overt diabetes mellitus. Dan. Med. Bull. (1998) 45:495\u2013509.","journal-title":"Dan. Med. Bull."},{"key":"e_1_2_1_15_1","doi-asserted-by":"crossref","unstructured":"LUP VR STYS SJ: Reccurrence of gestational diabetes in subsequent pregnancies. In: Gestational Diabetes. Weiss PAM Coustan DR (Eds) Springer-Verlag Vienna Austria (1988):123\u2013126.","DOI":"10.1007\/978-3-7091-8925-2_10"},{"key":"e_1_2_1_16_1","first-page":"69","article-title":"Cooperative Research Group","volume":"78","author":"HAPO Study","year":"2002","unstructured":"HAPO, Study Cooperative Research Group. The Hyperglycemia and Adverse Pregnancy (HAP 0) Study. Int. I Gyn. Obstet. (2002) 78:69\u201377.","journal-title":"The Hyperglycemia and Adverse Pregnancy (HAP 0) Study. Int. I Gyn. Obstet."},{"key":"e_1_2_1_17_1","unstructured":"\u2022\u2022A study of seminal importance that shouldhelp better define the relationship throughout a range of maternal glycemia and maternal and perinatal outcome."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.108085"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0020-7292(02)00129-7"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"ALBERTI KG ZIMMET PZ: Definition diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. (1998) 15:539\u2013553.","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"e_1_2_1_21_1","first-page":"525","article-title":"ACOG Practice Bulletin","volume":"98","author":"THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS COMMITTEE ON PRACTICE BULLETINS - OBSTETRICS","year":"2001","unstructured":"THE AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS COMMITTEE ON PRACTICE BULLETINS - OBSTETRICS: ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. Obstet. Gynecol (2001) 98:525\u2013538.","journal-title":"Clinical management guidelines for obstetrician-gynecologists. Obstet. Gynecol"},{"key":"e_1_2_1_22_1","unstructured":"\u2022\u2022An inclusive summary of the controversieswhich remain to be unraveled in GD along with sensible suggestions for clinical practice."},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.6.933"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431608"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.11.5.402"},{"key":"e_1_2_1_26_1","unstructured":"\u2022\u2022Important because it appears that some-many women with GD actually had undiagnosed pre-existing DM."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.3.3.458"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.2.S74"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(95)90580-4"},{"key":"e_1_2_1_30_1","first-page":"146","article-title":"Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes","volume":"173","author":"SEWER M","year":"1995","unstructured":"SEWER M, NAYLOR CD, GARE DJ et al.: Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am. Obstet. Gynecol (1995) 173:146\u2013156.","journal-title":"The Toronto Tri-Hospital Gestational Diabetes Project. Am. Obstet. Gynecol"},{"key":"e_1_2_1_31_1","first-page":"99","article-title":"Biphasic effects of maternal metabolism on fetal growth","volume":"40","author":"METZGER BE","year":"1991","unstructured":"METZGER BE: Biphasic effects of maternal metabolism on fetal growth. Quintessential expression of fuel-mediated teratogenesis. Diabetes (1991) 40:99\u2013105.","journal-title":"Quintessential expression of fuel-mediated teratogenesis. Diabetes"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02133967"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.2.S121"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198302033080502"},{"key":"e_1_2_1_35_1","first-page":"622","article-title":"BAIRD HR,CARRAHER MJ, BENNETT PH, KNOWLER WC: Congenital susceptibility to NIDDM","volume":"37","author":"PETTITT DJ","year":"1988","unstructured":"PETTITT DJ, ALECK KA, BAIRD HR,CARRAHER MJ, BENNETT PH, KNOWLER WC: Congenital susceptibility to NIDDM. Role of intrauterine environment. Diabetes (1988) 37:622\u2013628.","journal-title":"Role of intrauterine environment. Diabetes"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.18.5.611"},{"key":"e_1_2_1_37_1","unstructured":"HUNTER DJS KEIRSE MJNC: Gestational diabetes in effective care. Pregnancy and Childbirth. In: Chalmers I"},{"key":"e_1_2_1_38_1","unstructured":"\u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022 Enkin M Kierse M (Eds) Oxford University Press Oxford (1989):403\u2013410."},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500050087031"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(87)80045-5"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90369-4"},{"key":"e_1_2_1_42_1","first-page":"435","article-title":"Examination, 1992 Update: 1","volume":"147","author":"ANONYMOUS","year":"1992","unstructured":"ANONYMOUS: Periodic Health Examination, 1992 Update: 1. Screening for gestation diabetes mellitus. Canadian Task Force on the Periodic Health Examination. CMAJ(1992) 147:435\u2013443.","journal-title":"Screening for gestation diabetes mellitus. Canadian Task Force on the Periodic Health Examination. CMAJ"},{"key":"e_1_2_1_43_1","unstructured":"PEDERSEN' The Pregnant Diabetic andher Newborn: Problems and Management. 2nd edn. Williams & Wilkins Baltimore (1977) 1:280. Munksgaard Copenhagen Denmark."},{"key":"e_1_2_1_44_1","unstructured":"HOD M BAR J PELEDY: Antepartum management protocol: timing and mode of delivery in women with gestational diabetes. Diabetes Care (1998) 21\\(Suppl. 2):B113\u2013B117."},{"key":"e_1_2_1_45_1","unstructured":"PERSSON B HANSON U: Neonatal morbidities in gestational diabetes mellitus. Diabetes Care (1998) 21\\(Suppl. 2):B79\u2013B84."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001648-200011000-00013"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1080\/791200705"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(01)00416-X"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00268.x"},{"key":"e_1_2_1_50_1","unstructured":"\u2022\u2022Important description of outcomes in GD."},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"e_1_2_1_52_1","unstructured":"\u2022\u2022Innovative approach to primary preventionof type 2 DM."},{"key":"e_1_2_1_53_1","unstructured":"GLUECK CJ WANG P SIEVE-SMITH L GOLDENBERG N: Pre-pregnancy lowering of insulin glucose insulin resistance and weight by metformin is maintained through pregnancy in women with polycystic ovary syndrome. J. Invest. Med. (2002) 50:172A. (Abstract)."},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.8.7756"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.01123.x"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1440509"},{"key":"e_1_2_1_57_1","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"LEGRO RS","year":"1999","unstructured":"LEGRO RS, KUNSELMAN AR, DODSON WC, DUNAIF A: Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. Endocrinol Metab. (1999) 84:165\u2013169.","journal-title":"Endocrinol Metab"},{"key":"e_1_2_1_58_1","unstructured":"\u2022\u2022Excellent analysis of predictors for risk fortype 2 DM and impaired glucose tolerance in PCOS."},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1080\/gye.15.5.373.380"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/16.9.1995"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.1.141"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2001.109596"},{"key":"e_1_2_1_63_1","unstructured":"\u2022\u2022Thorough epidemiological study ofmetabolic syndrome and PCOS."},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2000.00884.x"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.6.1050"},{"key":"e_1_2_1_66_1","doi-asserted-by":"crossref","unstructured":"SOLOMON CG HU FB DUNAIF A et al.: Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. \"AMA (2001) 286:2421\u20132426.","DOI":"10.1001\/jama.286.19.2421"},{"key":"e_1_2_1_67_1","unstructured":"\u2022\u2022Important epidemiological assessment ofcovert PCOS and type 2 DM."},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010492"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292703"},{"key":"e_1_2_1_70_1","unstructured":"\u2022\u2022Seminal study of relationship of insulinresistance to NIDDM."},{"key":"e_1_2_1_71_1","first-page":"265","article-title":"Induction of insulin resistance by androgens and estrogens","volume":"79","author":"POLDERMAN KH","year":"1994","unstructured":"POLDERMAN KH, GOOREN LJ, ASSCHEMAN H, BAKKER A, HEINE RJ: Induction of insulin resistance by androgens and estrogens. J. Endocrinol Metabolism (1994) 79:265\u2013271.","journal-title":"J. Endocrinol Metabolism"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8261"},{"key":"e_1_2_1_73_1","unstructured":"\u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022 \u2022\u2022Largest placebo-controlled double-blind study of metformin in PCOS to date."},{"key":"e_1_2_1_74_1","first-page":"139","article-title":"Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation","volume":"85","author":"MOGHETTI P","year":"2000","unstructured":"MOGHETTI P, CASTELLO R, NEGRI C, TOSI F, PERRONE F, CAPUTO MI: Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: a randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation. Clin. Endocrinol Metab. (2000) 85:139\u2013146.","journal-title":"Clin. Endocrinol Metab."},{"key":"e_1_2_1_75_1","unstructured":"\u2022\u2022Well carried-out double-blind study ofmetformin in PCOS."},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01666-6"},{"key":"e_1_2_1_77_1","unstructured":"\u2022\u2022Safe non-teratogenic reduction of firsttrimester SABs in PCOS with metformin."},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","unstructured":"GLUECK CJ WANG P GOLDENBERG N SIEVE-SMITH L: Pregnancy outcomes among women with polycystic ovarian syndrome treated with metformin. Hum. Reprod. (2002) 17:(In Press.)","DOI":"10.1093\/humrep\/17.11.2858"},{"key":"e_1_2_1_79_1","unstructured":"\u2022\u2022The largest study of pregnancy outcomesand gestational diabetes in women with PCOS."},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.9.4.430"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(16)33833-9"},{"key":"e_1_2_1_82_1","unstructured":"\u2022\u2022Influential cutting edge diagnostic studiesin GD."},{"key":"e_1_2_1_83_1","unstructured":"Gestational diabetes mellitus. Diabetes Care (2000) 23\\(Suppl. 1):577\u2013579."},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-277X.2002.00344.x"},{"key":"e_1_2_1_85_1","unstructured":"WALKINSHAW SA: Dietary regulation for 'gestational diabetes'. Cochrane Database Syst. Rev (2000) 2:CD000070."},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.67.7.481"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.4.460"},{"key":"e_1_2_1_88_1","first-page":"600","article-title":"The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes","volume":"91","author":"MAJOR CA","year":"1998","unstructured":"MAJOR CA, HENRY MJ, DE VECIANA M, MORGAN MA: The effects of carbohydrate restriction in patients with diet-controlled gestational diabetes. Obstet. Gyn. (1998) 91:600\u2013604.","journal-title":"Obstet. Gyn."},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1479-828X.1999.tb03363.x"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0895(199612)12:4<287::AID-DMR171>3.0.CO;2-E"},{"key":"e_1_2_1_91_1","first-page":"1647","article-title":"The recurrence of gestational diabetes: could dietary differences in fat intake be an explanation?","volume":"1997","author":"MOSES RG","unstructured":"MOSES RG, SHAND JL, TAPSELL LC: The recurrence of gestational diabetes: could dietary differences in fat intake be an explanation? Diabetes Care (1997) 20: 1647-1650.","journal-title":"Diabetes Care"},{"key":"e_1_2_1_92_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-1999-6801"},{"key":"e_1_2_1_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ejcn.1601193"},{"key":"e_1_2_1_94_1","doi-asserted-by":"crossref","unstructured":"GARG A: High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am. J. Chit. Nutr. (1998) 67(3 Suppl.):577S\u2013582S.","DOI":"10.1093\/ajcn\/67.3.577S"},{"key":"e_1_2_1_95_1","unstructured":"\u2022\u2022Influential meta-analysis of utility ofmonounsaturated fats in DM."},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.1.202"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009223"},{"key":"e_1_2_1_98_1","unstructured":"DYCK RF SHEPPARD MS CASSIDY H CHAD K TAN L VAN VLIET SH: Preventing NIDDM among aboriginal people: is exercise the answer? Description of a pilot project using exercise to prevent gestational diabetes. Int. Circumpolar Health (1998) 57\\(Supp1.1):375\u2013378."},{"key":"e_1_2_1_99_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(89)90534-6"},{"key":"e_1_2_1_100_1","first-page":"960","article-title":"Prophylactic insulin in the management of gestational diabetes","volume":"75","author":"THOMPSON DJ","year":"1990","unstructured":"THOMPSON DJ, PORTER KB, GUNNELLS DJ, WAGNER PC, SPINNATO JA: Prophylactic insulin in the management of gestational diabetes. Obstet. Gynecol (1990) 75:960\u2013964.","journal-title":"Obstet. Gynecol"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-197803000-00010"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-9136(199709)14:9<762::AID-DIA485>3.0.CO;2-C"},{"key":"e_1_2_1_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.319.7219.1223"},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00412.x"},{"key":"e_1_2_1_105_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.12.2078"},{"key":"e_1_2_1_106_1","first-page":"481","article-title":"Controversies in the diagnosis and treatment of gestational diabetes","volume":"67","author":"JOVANOVIC L","year":"2001","unstructured":"JOVANOVIC L: Controversies in the diagnosis and treatment of gestational diabetes. Cleveland Cl. Med. (2001) 67:481\u2013488.","journal-title":"Cleveland Cl. Med."},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/94.5.255"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.9.1422"},{"key":"e_1_2_1_109_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-19987"},{"key":"e_1_2_1_110_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP.6.1.98"},{"key":"e_1_2_1_111_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199710023371414"},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90078-7"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200010193431601"},{"key":"e_1_2_1_114_1","doi-asserted-by":"crossref","unstructured":"DORNHORST A: A comparison of glyburide and insulin in women with gestational diabetes mellitus. Diabet. Med. (2001) 18\\(Suppl. 3):12\u201314.","DOI":"10.1046\/j.1464-5491.2001.00001-6.x"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00314.x"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0890-6238(01)00122-8"},{"key":"e_1_2_1_117_1","unstructured":"GLUECK CJ SIEVE-SMITH L GOLDENBERG N WANG P: Metformin improves pregnancy outcomes in 295 women (328 pregnancies) with polycystic ovary syndrome. \"Invest Med (2002) 50:163A (Abstract)."},{"key":"e_1_2_1_118_1","unstructured":"\u2022\u2022Metformin appears to be safe and non-teratogenic during pregnancy."},{"key":"e_1_2_1_119_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.2.8207"},{"key":"e_1_2_1_120_1","unstructured":"\u2022\u2022Important study confirming the safety ofmetformin use during pregnancy in women with PCOS."},{"key":"e_1_2_1_121_1","unstructured":"GLUECK CJ SIEVE-SMITH L GOLDENBERG N WANG P: Normal growth in the first year of life in 154 infants with gestation 37 weeks and whose mothers with polycystic ovary syndrome conceived on and took metformin during pregnancy. J. Invest. Med. (2002) 50:172A. (Abstract)."},{"key":"e_1_2_1_122_1","unstructured":"GLUECK CJ SIEVE-SMITH L GOLDENBERG N et al.: Normal developmental milestones in the first year of life in 154 infants with gestation 37 weeks and whose mothers with polycystic ovary syndrome conceived on and took metformin during pregnancy. I Invest. Med. (2002) 50:172A. (Abstract)."},{"key":"e_1_2_1_123_1","doi-asserted-by":"crossref","unstructured":"COETZEE EJ JACKSON WP: The management of non-insulin-dependent diabetes during pregnancy. Diabetes Res. Clin. Piaci (1985\u20136) 1:281\u2013287.","DOI":"10.1016\/S0168-8227(86)80036-5"},{"key":"e_1_2_1_124_1","first-page":"635","article-title":"Oral hypoglycaemics in the first trimester and fetal outcome","volume":"65","author":"COETZEE EJ","year":"1984","unstructured":"COETZEE EJ, JACKSON WP: Oral hypoglycaemics in the first trimester and fetal outcome. S. Air. Med. J. (1984) 65:635\u2013637","journal-title":"S. Air. Med. J."},{"key":"e_1_2_1_125_1","unstructured":"\u2022\u2022Historically important because ofdocumentation of lack of teratogenicity of metformin during pregnancy."},{"key":"e_1_2_1_126_1","first-page":"795","article-title":"Pregnancy in established non-insulin-dependent diabetics","volume":"58","author":"COETZEE EJ","year":"1980","unstructured":"COETZEE EJ, JACKSON WP: Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Grote Schuur Hospital. S. Afr. Med. (1980) 58:795\u2013802.","journal-title":"A five-and-a-half year study at Grote Schuur Hospital. S. Afr. Med."},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01221950"},{"key":"e_1_2_1_128_1","first-page":"1113","article-title":"Side-effects of metformin","volume":"56","author":"JACKSON WP","year":"1979","unstructured":"JACKSON WP, COETZEE EJ: Side-effects of metformin. S. Air. Med. J. (1979) 56:1113\u20131114.","journal-title":"S. Air. Med. J."},{"key":"e_1_2_1_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03266-6"},{"key":"e_1_2_1_130_1","unstructured":"\u2022\u2022Metformin for ovulation induction andconception."},{"key":"e_1_2_1_131_1","unstructured":"GLUECK CJ KOYABASHI S SIEVE- SMITH L WANG P: Metformin reduces gestational diabetes from 29% to 2.4% in women with polycystic ovary syndrome. J. Invest. Med. (2002) 50:175A (Abstract)."},{"key":"e_1_2_1_132_1","doi-asserted-by":"publisher","DOI":"10.1002\/tera.1420490405"},{"key":"e_1_2_1_133_1","first-page":"365","article-title":"Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy","volume":"13","author":"IWAMOTO Y","year":"1996","unstructured":"IWAMOTO Y, KOSAKA K, KUZUYA T, AKANUMA Y, SHIGETA Y, KANEKO T: Effects of troglitazone: a new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy. Diabetes Care (1996) 13:365\u201370.","journal-title":"Diabetes Care"},{"key":"e_1_2_1_134_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199411033311803"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2796"},{"key":"e_1_2_1_136_1","unstructured":"\u2022\u2022Strong evidence that treatment withinsulin-sensitising drugs can reduce the development of type 2 DM in women with previous GD at high risk for type 2 DM."},{"key":"e_1_2_1_137_1","first-page":"568","article-title":"Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus","volume":"86","author":"DM HOMCO C","year":"2001","unstructured":"DM HOMCO C, SIVAN E, CHEN X, REECE EA, BODEN G: Insulin secretion during and after pregnancy in patients with gestational diabetes mellitus. J. Clin. Endocrine]. Metab. (2001) 86:568\u2013573.","journal-title":"J. Clin. Endocrine]. Metab."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.3.11.1557","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T10:08:15Z","timestamp":1770890895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.3.11.1557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":136,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1517\/14656566.3.11.1557"],"URL":"https:\/\/doi.org\/10.1517\/14656566.3.11.1557","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]}}}